| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/30/2013 | EP2551281A1 Splice variants of GDNF and uses thereof |
| 01/30/2013 | EP2551280A2 Contraceptive peptides derived from spider venom |
| 01/30/2013 | EP2550973A1 Wound spray |
| 01/30/2013 | EP2550972A1 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/30/2013 | EP2550971A1 Devices and Methods for Integrated Continuous Manufacturing of Biological Molecules |
| 01/30/2013 | EP2550958A1 Controlled release formulations of lipocalin muteins |
| 01/30/2013 | EP2550532A1 Method of supressing cancer, increasing weight loss and/or increasing insulin sensitivity |
| 01/30/2013 | EP2550359A1 Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof |
| 01/30/2013 | EP2550298A2 Compositions and methods for self-adjuvanting vaccines against microbes and tumors |
| 01/30/2013 | EP2550014A1 Papillomavirus virus-like particle or capsomere formulation and its use as microbicide |
| 01/30/2013 | EP2550013A1 Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 01/30/2013 | EP2550010A1 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 01/30/2013 | EP2550009A1 Dendritic cell inhibitory proteins from ticks |
| 01/30/2013 | EP2550008A2 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer |
| 01/30/2013 | EP2550007A1 Desmopressin for reducing nocturnal voids |
| 01/30/2013 | EP2550006A1 Bmp-4 peptides&methods of use |
| 01/30/2013 | EP2550005A1 Transdermal administration of peptides |
| 01/30/2013 | EP2549992A2 Methods of treatment using stem cell mobilizers |
| 01/30/2013 | EP2549990A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 01/30/2013 | CN102906259A Polynucleotide encoding acyl-coa synthetase homolog and method for using the same |
| 01/30/2013 | CN102906251A Enzyme granules |
| 01/30/2013 | CN102906120A Recombinant human G-CSF dimer and use thereof for treatment of neurological diseases |
| 01/30/2013 | CN102906110A Antimicrobial agents based on hemin derivatives |
| 01/30/2013 | CN102906105A Compounds and their use |
| 01/30/2013 | CN102905730A Zwitterionic polymer bioconjugates and related methods |
| 01/30/2013 | CN102905722A Long-acting Y2 receptor agonists |
| 01/30/2013 | CN102905721A Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 01/30/2013 | CN102905720A New uses of oxytocin-like molecules and related methods |
| 01/30/2013 | CN102905719A Methods for treating combined radiation and thermal injury |
| 01/30/2013 | CN102905718A Methods of purifying polypeptides |
| 01/30/2013 | CN102905717A Composition for transnasal administration and method for producing same |
| 01/30/2013 | CN102905716A Method for treating liver disorders with receptor associated protein ( irp) peptide-fucosidase inhibitor conjugates |
| 01/30/2013 | CN102905703A Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases, etc. |
| 01/30/2013 | CN102901826A New potential human cytokine TMEM98 and uses thereof |
| 01/30/2013 | CN102898528A Calreticulin-soluble programmed death receptor 1 fusion protein, and preparation method and purpose thereof |
| 01/30/2013 | CN102898526A Tumor necrosis factor-related apoptosis-inducing ligand fusion protein, its preparation and application |
| 01/30/2013 | CN102898512A Recombinant plectasin as well as preparation method and application of recombinant plectasin |
| 01/30/2013 | CN102898508A Polypeptide for enclosing TGF-beta acceptor or IL-10 acceptor, pharmaceutical composition and application |
| 01/30/2013 | CN102898507A Thrombolysis oligopeptide-imidazolidine binary conjugate, preparation method and uses thereof |
| 01/30/2013 | CN102898506A RPAK/imidazolidine/RGD ternary conjugate, preparation method and uses thereof |
| 01/30/2013 | CN102898505A ARPAK/imidazolidine/RGD ternary conjugate, preparation method and uses thereof |
| 01/30/2013 | CN102898504A Antioxidation active synthetic peptide and purpose thereof |
| 01/30/2013 | CN102898503A Antioxidation-activity synthetic peptides and application thereof |
| 01/30/2013 | CN102898502A Coumarin derivative, and its preparation method and application |
| 01/30/2013 | CN102895704A Biological activity factor composition for promoting ossification and vascularization |
| 01/30/2013 | CN102895676A New application of P53 gene |
| 01/30/2013 | CN102895668A Method of delivering a protein into a cell |
| 01/30/2013 | CN102895658A Application of Cystatin C in treating cerebral vasospasm after subarachnoid hemorrhage |
| 01/30/2013 | CN102895657A Method for constructing asthma model of nonhuman mammal |
| 01/30/2013 | CN102895656A Adenosine triphosphate-coenzyme-insulin compound-containing pharmaceutical composition |
| 01/30/2013 | CN102895655A Application of haemopoietin microspheres in preparation of medicaments for treating parkinsonism |
| 01/30/2013 | CN102895654A Application of erythropoietin to preparation of medicines for treating Parkinson's disease motion complications |
| 01/30/2013 | CN102895653A Application of Cystatin C in treating early-stage brain damage after subarachnoid hemorrhage |
| 01/30/2013 | CN102895652A Method for promoting osteoblast differentiation by using Runx2 and Osterix and application thereof |
| 01/30/2013 | CN102895651A Chinese caterpillar fungus oral preparation and preparation method thereof |
| 01/30/2013 | CN102895650A Application of cyclotides ingredients in zizyphus jujube roots |
| 01/30/2013 | CN102895649A Medicinal composition for treating liver injury and method for preparing medicinal composition for treating liver injury |
| 01/30/2013 | CN102895648A Clinical nutrition emulsion and preparation method thereof |
| 01/30/2013 | CN102895179A Argatroban formulation comprising an acid as solubilizer |
| 01/30/2013 | CN102895176A Method for preparing porous gel containing recombinant human endostatin |
| 01/30/2013 | CN102409010B Gamma-proteobacteria and application thereof |
| 01/30/2013 | CN102309750B Special conditioning and nourishing film for use at genital of woman |
| 01/30/2013 | CN102304170B Horn polypeptide, and separation method and antioxidation application thereof |
| 01/30/2013 | CN102286084B Gingko biloba defensin, encoding gene and application thereof |
| 01/30/2013 | CN102250212B Matrix metalloproteinase-9 polypeptide inhibitor 5 and use thereof |
| 01/30/2013 | CN102228676B Heparolysate injection pharmaceutical composition |
| 01/30/2013 | CN102180949B Polypeptide capable of specifically combining vessel endothelial growth factor and application thereof |
| 01/30/2013 | CN102078596B Application of toad peptide antibiotics in preparing drugs for treating hemorrhoids |
| 01/30/2013 | CN101947315B Application of Chinese medicinal bitter apricot seeds in lysozyme sodium alginate microspheres |
| 01/30/2013 | CN101939021B Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
| 01/30/2013 | CN101928740B MMP14 double-target efficient binding peptide, method for obtaining polypeptide structure sequence and application of target compound |
| 01/30/2013 | CN101437535B Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection |
| 01/30/2013 | CN101432295B Application of peptide from lactoprotein |
| 01/30/2013 | CN101277714B Methods for treating immune mediated neurological diseases |
| 01/30/2013 | CN101189023B 监测和调制hgf/hgfr活性 Monitoring and modulation hgf / hgfr activity |
| 01/30/2013 | CN101039689B Topical compositions and methods for epithelial-related conditions |
| 01/30/2013 | CN101027317B HPV vaccine comprising peptides from host cell proteins |
| 01/29/2013 | US8362297 High protein supplement |
| 01/29/2013 | US8362231 RNA interference mediating small RNA molecules |
| 01/29/2013 | US8362223 Hemopoietin receptor protein, NR10 |
| 01/29/2013 | US8362218 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof |
| 01/29/2013 | US8362216 Method of detection using antibodies that specifically bind hedgehog-derived polypeptides |
| 01/29/2013 | US8362206 Chimeric proteins and uses thereof |
| 01/29/2013 | US8362205 Delocalization molecules and use thereof |
| 01/29/2013 | US8362202 using polypeptides that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule to inhibit Fc-mediated immune complex formation; rheumatoid arthritis |
| 01/29/2013 | US8362084 Histone deacetylases, and uses related thereto |
| 01/29/2013 | US8361987 DNA vaccines encoding heat shock proteins |
| 01/29/2013 | US8361978 Use of herpes vectors for tumor therapy |
| 01/29/2013 | US8361971 Tablet formulation of ezatiostat |
| 01/29/2013 | US8361970 Growth factor binding molecules |
| 01/29/2013 | US8361969 Designer cyclic peptides—HIV gp120 antagonists and their applications |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | US8361967 Beta sheet inhibiting peptides for preventing and/or treating Alzheimer's Disease |
| 01/29/2013 | US8361966 Use of interleukin-11 as therapeutic agent for heart disease |
| 01/29/2013 | US8361965 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen, and pharmaceutical composition thereof |
| 01/29/2013 | US8361964 Growth hormone releasing factor (GRF) analogs and uses thereof |
| 01/29/2013 | US8361963 Uses of FGF21 polypeptides comprising two or more mutations |
| 01/29/2013 | US8361962 Tricyclic inhibitors of JAK |
| 01/29/2013 | US8361961 O-linked glycosylation of peptides |
| 01/29/2013 | US8361960 Periostin-induced pancreatic regeneration |